Navigation Links
NCI Funded Clinical Trial to Study Treatment of Breast Cancer Using Cryoablation
Date:10/28/2008

invasive non-surgical procedure that uses extreme cold to destroy tumors. The Sanarus Visica System has predominately been used in the cryoablation of non-cancerous tumors called fibroadenomas since its initial FDA market clearance in March of 2002. This office-based procedure, which usually takes less than 20 minutes, involves placing a small needle into the center of the tumor using ultrasound guidance and subsequently freezing and killing the tumor. The safety and efficacy of cryoablation have been well established in over 2,000 fibroadenomas that have been treated with the System to date.

"We are very pleased that ACOSOG chose cryoablation as the preferred thermal ablation modality over other ablation modalities such as radio- frequency (RF), interstitial laser, microwave, or focused ultrasound," said John F. Howe, President and Chief Executive Officer of Sanarus. "We are equally pleased that the award winning Sanarus Visica 2 Treatment System was selected as the preferred cryoablation system. This speaks volumes to the future potential of our System in expanded applications."

The Visica 2 System recently received national recognition with a Wall Street Journal Technology Innovation Award; and the Humanitarian Application of the Year Award from National Instruments.

The ACOSOG is one of 10 cooperative groups funded by the National Cancer Institute (NCI) to develop and coordinate multi-center clinical trials and is the only cooperative group whose primary focus is the surgical management of patients with malignant solid tumors. Additional information regarding the ACOSOG clinical trial is available to ACOSOG members via the organizations website http://www.ACOSOG.org under the heading of the Z1072 Clinical Protocol.

About Sanarus Medical

Sanarus Medical is based in Pleasanton, Calif., and is focused on providing patients and physicians with minimally invasive, office-based breast
'/>"/>

SOURCE Sanarus Medical
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Potential Breakthrough Cancer Treatment Emerges from MIPS-Funded Clinical Trial Teaming CSA Medical Inc. and University of Maryland Researchers
2. Premier Research Honored as Clinical Research Team of the Year at 2008 GCPj Awards
3. PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)
4. Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
5. Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
6. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
7. Qualia Clinical Services Chooses ALPHADAS(R) for Phase I Clinical Trials
8. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
9. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
10. Multi-Centre European Clinical Trial Shows Advanced Dysplasia and Early Cancer of Esophagus Cured With Combined Endoscopic Resection and Radiofrequency Ablation With HALO Ablation System
11. CeNeRx BioPharma Initiates Phase II Clinical Trial of Its Novel Antidepressant Agent Tyrima(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014 /CNW/ - ... is being recalled after Health Canada tests confirmed it ... health risks (beta-methylphenethylamine and phenylpropylmethylamine). The distributor, Empire Health ... recalling the product from retail stores across ... building purposes, including for weight loss and increased energy. ...
(Date:12/24/2014)... 24, 2014  Commonwealth Cornerstone Group (CCG) today announced the ... on Tuesday to help fund the expansion and consolidation of ... Sharon . PHN is the ... . It is the largest employer in ... people on staff. Currently, PHN Sharon offers scattered ...
(Date:12/24/2014)... N.J. , Dec. 24, 2014 ... a late-stage biopharmaceutical company developing products that address ... oncology and biodefense, announced today that on December ... public offering. The Company raised approximately ... and intends to use the net proceeds from ...
Breaking Medicine Technology:"Jetfuel Superburn" recalled after Health Canada tests find undeclared drug ingredients 2Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 2Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 3Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3
... ARBOR, Mich., May 14, 2012  Synthetic Biologics, Inc. (NYSE ... DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses, ... Senior Vice President of Clinical & Regulatory Affairs. In ... design and implementation of all aspects of clinical development, ...
... 11, 2012 Dynatronics Corporation (NASDAQ: DYNT ) ... months ended March 31, 2012 during the morning of Tuesday, ... conference call for investors later that day at 3:30 p.m. ... month periods.  Those interested in participating should call (800) 676-3536. ...
Cached Medicine Technology:Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs 2Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs 3
(Date:12/26/2014)... WA (PRWEB) December 26, 2014 “Many ... deal with personal injury claim issues and phone calls ... recently released an article featuring their free eBook ... exceptionally helpful eBook on pedestrian and bicycle auto accident ... attorney is fully capable of professionally handling their case ...
(Date:12/25/2014)... December 26, 2014 The microscopy ... of 7.2% to reach $5,756.0 million by 2019. ... microscopy market. The electron microscopes product segment is ... forecast period. , Rising focus on nanotechnology, technological ... of the microscopy market. , Get Full Copy ...
(Date:12/25/2014)... December 25, 2014 Product liability lawsuits ... hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward ... an Order issued in the U.S. District Court, Northern ... convene an open conference on January 7, 2015, at ... Courthouse in West Palm Beach, Florida. The Conference is ...
(Date:12/25/2014)... Recently, BellasDress has launched ... wedding dresses. BellasDress has chosen their best-selling lace wedding ... for the holiday season. , Now, BellasDress.com features ... gowns here at discount prices. The business hopes everyone ... website. , “All our elegant products are ...
(Date:12/25/2014)... By Dennis Thompson ... -- Very sick children with complex chronic illnesses can receive ... a "medical home," with easy access to a team of ... were less likely to become seriously ill and need either ... received treatment at an enhanced medical home clinic at the ...
Breaking Medicine News(10 mins):Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3
... teens, TOPEKA, Kan., Oct. 19 Attorney General ... with new 30-second,radio public service announcements set to air ... coincide with the busy fall season and will,air more ... November. "With teens heading off to parties, dances ...
... recent study by Celent, a leading,financial services technology research ... of eight firms leading the way as a change ... transactions. Celent,s Healthcare Banking research service based its ... Mellon,s Treasury Services division to,apply its scale, technology and ...
... SPRINGS, Colo., Oct. 19 ,Spectranetics Corporation (Nasdaq: ... 2007 third quarter financial results prior to market ... host an,investment-community conference call beginning at 9:00 a.m. ... 31 to discuss those results,and to answer questions. ...
... SANTA ANA, Calif., Oct. 19 Today, Integrated,Healthcare ... owner of,four Orange County hospitals, announced that effective ... of all of its debt instruments. The,Company said ... with Medical,Capital Corporation and affiliates of Anaheim, California, ...
... Company,(Nasdaq: PRGO ; TASE) today announced that it ... on Thursday, November 1, 2007 at,approximately 8:00 a.m. (ET). ... (ET) hosted by Joseph C. Papa, Perrigo,s President and ... live via webcast to interested,parties on the Perrigo website ...
... AAFP President Michael Fleming, MD will serve as Digital,s Medical ... Director ... Healthcare, a Wake,Forest, NC company specializing in retinal risk assessment for ... for Primary Care. In his new role, Dr. Fleming will,provide Digital ...
Cached Medicine News:Health News:Morrison Takes Aim at Underage Drinking in New Radio Campaign 2Health News:The Bank of New York Mellon Recognized as Change Agent Shaping the Direction of Healthcare Transaction Processing 2Health News:Spectranetics to Hold 2007 Third Quarter Financial Results Conference Call on October 31 2Health News:IHHI Announces Completion of Re-Financing 2Health News:Digital Healthcare Announces Dr. Michael Fleming Joins Executive Team as Medical Director 2
... drape sheets with a low-profile, roomy ... the operative site during arthroscopic surgery. ... ports for drainage. , ,The ... a standard pack, or in custom ...
... includes bed side and near patient testing ... This growth has posed unique problems for ... and quality responsibility to decentralized areas focused ... Compounding the problem is the reality of ...
... First Consolidated Workstation to Automate Deparaffinization, ... Staining,Now you can perform deparaffinization, pretreatment, ... routine slide washing with a single ... preprogrammed Vysis protocols for fluorescence in ...
... sample preparation platform is an efficient system ... from patient samples using novel magnetic particle ... sample preparation and is cabable of processing ... a 1 ml sample volume., ,This platform ...
Medicine Products: